We are Science Accelerated
We are KCAS Bio, your full-service, global bioanalytical CRO partner with the expertise, capacity and flexibility sponsors require.
Bioanalytical CRO service excellence
We take a consultative approach to our discovery and bioanalytical services, giving our clients' confidence their needs are understood, their objectives will be met, and our promises kept. We consistently benchmark, evaluate and optimize our operations so we can help scientific innovators and investors.
We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings.
Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management.
Spectral Flow Cytometry on a Global Scale
KCAS Bio is the only bioanalytical laboratory with globally harmonized Cytek spectral flow cytometers, with sites in the US, EU and Australia.
Global biomarker and bioanalytical CRO solutions
KCAS Bio is an established bioanalytical CRO with over 40 years' experience. We are very mindful of the human and financial impact of drug development delays. Through our unique approach to capacity planning, we prepare the right expertise with the right capacity and equipment so that we can keep development moving smoothly. Our clients consider us a reliable partner because we strive to minimize downtime, avoid delays, and keep lead times as short as possible.
Find exactly what you’re looking for
Search for specific services, platforms, instrumentation, or scientific insights.
KCAS Bio scientific insights
Blogs
As the bioanalytical market evolves at a rapid pace, KCAS Bio stands at the forefront, offering an innovative approach to challenges and opportunities alike. Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with…
Blogs
Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…
Blogs
Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…
Advancing great people and great science
We make nurturing new talent a strategic priority, so that teams are dynamic and constantly improving. We provide a supportive environment for continuous learning and training where you can become your best.
What our clients say
We consistently earn our clients’ trust based on our reputation for transparency, delivering error-free data and keeping our promises.
Tell us how we can help with your project
We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.